Nanjing Well Pharmaceutical GroupLtd Temettü
Temettü kriter kontrolleri 3/6
Nanjing Well Pharmaceutical GroupLtd is a dividend paying company with a current yield of 1.2% that is well covered by earnings.
Anahtar bilgiler
1.2%
Temettü verimi
0.3%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 1.5% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | -0.6% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.300 |
| Ödeme oranı | 28% |
Son temettü güncellemeleri
Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Whilst dividend payments have been stable, 603351 has been paying a dividend for less than 10 years.
Büyüyen Temettü: 603351 has only been paying a dividend for 5 years, and since then payments have fallen.
Piyasaya Karşı Temettü Getirisi
| Nanjing Well Pharmaceutical GroupLtd Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (603351) | 1.2% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Chemicals) | 1.8% |
| Analist tahmini (603351) (3 yıla kadar) | n/a |
Önemli Temettü: 603351's dividend (1.2%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 603351's dividend (1.2%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonably low payout ratio (27.8%), 603351's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (25%), 603351's dividend payments are well covered by cash flows.